Protection by U-50,488H against beta-chlornaltrexamine antagonism of nitrous oxide antinociception in mice.
R M Quock, J Mueller
Index: Brain Res. 549(1) , 162-4, (1991)
Full Text: HTML
Abstract
Nitrous oxide antinociception in the abdominal constriction test was significantly reduced in mice pretreated intracerebroventricularly (i.c.v.) with beta-chlornaltrexamine (beta-CNA). However, this antagonism was reversed when the beta-CNA was co-administered i.c.v. with the kappa-opioid ligand U-50,488H but not the mu-opioid ligand CTOP. These findings further demonstrate that nitrous oxide antinociception in the mouse abdominal constriction paradigm is mediated by kappa- but not mu-opioid receptors.
Related Compounds
Related Articles:
2000-09-01
[J. Pharmacol. Exp. Ther. 294 , 933, (2000)]
1993-01-07
[Biochem. Pharmacol. 45(1) , 207-16, (1993)]
2001-09-14
[J. Biol. Chem. 276(37) , 34624-30, (2001)]
1992-01-01
[Life Sci. 51(11) , 869-85, (1992)]
2008-03-01
[Eur. Neuropsychopharmacol. 18(3) , 194-9, (2008)]